Clinical Trials Directory

Trials / Completed

CompletedNCT03775447

Fox BioNet Project: ECV-003

FoxBioNet: ECV (Extracellular Vesicle) 003

Status
Completed
Phase
Study type
Observational
Enrollment
38 (actual)
Sponsor
Michael J. Fox Foundation for Parkinson's Research · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to optimize pre-analytical cerebrospinal fluid (CSF) extracellular vesicle isolation protocols for increasing the detection of LRRK2 activity in human CSF

Detailed description

Specific aims to accomplish this objective are: PRIMARY OBJECTIVES: * To evaluate a series of extracellular vesicle isolation methods for their ability to enrich for LRRK2 and increase the detection of LRRK2 in CSF samples. * To compare the measurements of LRRK2, p1292 LRRK2, Rabs and pRabs from the ECVs isolated using each method. * To assess the inter-lab reliability of each method SECONDARY OBJECTIVES * To assess the ability of the network of sites to efficiently conduct a study involving biosample collection for PD research. Efficiency will be assessed using measures of the time taken to meet specific milestones within the study * To assess the ability of the network to collect high quality biospecimens adhering to agreed-upon protocols. * To gauge the willingness of participants to participate in subsequent Fox BioNet studies

Conditions

Interventions

TypeNameDescription
PROCEDURELumbar PunctureLumbar Puncture for collection of Cerebrospinal Fluids

Timeline

Start date
2019-04-23
Primary completion
2019-12-18
Completion
2019-12-18
First posted
2018-12-14
Last updated
2021-09-08

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03775447. Inclusion in this directory is not an endorsement.